BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2014
View Archived Issues
Lundbeck characterizes novel brain-penetrant PDE2A inhibitor
Read More
Molecular Templates presents novel therapeutic candidate for multiple myeloma
Read More
Janssen presents novel FASN inhibitors for the treatment of cancer
Read More
AQP-5 expression and polymorphisms predict early breast cancer survival
Read More
Germline PIGA mutations linked to new genetic syndrome
Read More
Ace2 gene therapy reduces liver fibrosis in mice
Read More
Evotec presents novel FGFR-3 inhibitors
Read More
New series of ERK 2 inhibitors patented by Novartis
Read More
Sanofi patents new apelin receptor modulators
Read More
Pfizer discloses novel BACE inhibitors
Read More
Akebia Therapeutics completes enrollment in a phase IIb study of AKB-6548
Read More
IRM designs novel GPR119 receptor modulators
Read More
Mucosis enters into collaboration and license agreement with Changchun
Read More
Pivotal phase III study of veliparib begins in non-small cell lung cancer
Read More
Akron Biotech receives NIH grant for method to isolate stem cells
Read More
TT-genotype of IL-23R has protective effect in lung transplant recipients
Read More
Akros Pharma begins phase I study of JTT-251 in diabetes
Read More
Novel putative antisense mitochondrial RNA-based therapy for renal cell carcinoma
Read More
Cellmid signs MK Tribody agreement with Biotecnol
Read More
Dynavax initiates phase III trial to expand safety database for HBV vaccine
Read More
PanOptica completes financing round and starts dosing in phase I trial of anti-VEGF eye drop
Read More
FDA approves GSK's albiglutide BLA for type 2 diabetes
Read More
Kineta RLB joint venture formed to develop drugs for autoimmune disease
Read More
Wilson Therapeutics raises funding for development of Wilson's disease therapy
Read More
FDA approves trade name for Medac's subcutaneous methotrexate
Read More
BioAlliance and TopoTarget to merge
Read More